Show simple item record

dc.contributor.advisorHalonen, Marilyn J.en_US
dc.contributor.authorMiller, Alice Lorraine, 1953-
dc.creatorMiller, Alice Lorraine, 1953-en_US
dc.date.accessioned2013-04-03T13:21:38Z
dc.date.available2013-04-03T13:21:38Z
dc.date.issued1993en_US
dc.identifier.urihttp://hdl.handle.net/10150/278355
dc.description.abstractIdentifying predictive indicators of atopy could allow for the early intervention and/or prevention of atopic associated diseases within individuals identified to be at high risk. Two immunological factors advanced as candidates for such a role are sCD23 and sCD25. Soluble CD23 and CD25 expression were therefore examined in the cord blood of over 300 healthy newborns enrolled in the Tucson Children's Respiratory study. Additionally these factors were measured in sera drawn from these patients between the ages of 4-9. Determinations were made using commercially available sCD23 and sCD25 ELISA assays. Results indicate these markers are measurable in cord samples, they are not influenced by gender, and soluble CD23 and CD25 levels decrease with age. Increasing levels of sCD23 and sCD25 did not correlate with increasing expression of IgE. Experimental data derived in this study indicate these factors will not serve as independent, predictive indicators of future asthma, hayfever or eczema.
dc.language.isoen_USen_US
dc.publisherThe University of Arizona.en_US
dc.rightsCopyright © is held by the author. Digital access to this material is made possible by the University Libraries, University of Arizona. Further transmission, reproduction or presentation (such as public display or performance) of protected items is prohibited except with permission of the author.en_US
dc.subjectHealth Sciences, Immunology.en_US
dc.titleSerum levels of two immunological markers, the soluble low affinity receptor for IgE (sFCepsilonRII, sCD23) and soluble interleukin 2 receptor (sIL-2R), and their correlation with age, gender and the onset of childhood atopyen_US
dc.typetexten_US
dc.typeThesis-Reproduction (electronic)en_US
thesis.degree.grantorUniversity of Arizonaen_US
thesis.degree.levelmastersen_US
dc.identifier.proquest1353678en_US
thesis.degree.disciplineGraduate Collegeen_US
thesis.degree.nameM.S.en_US
dc.identifier.bibrecord.b29225334en_US
refterms.dateFOA2018-04-26T11:00:26Z
html.description.abstractIdentifying predictive indicators of atopy could allow for the early intervention and/or prevention of atopic associated diseases within individuals identified to be at high risk. Two immunological factors advanced as candidates for such a role are sCD23 and sCD25. Soluble CD23 and CD25 expression were therefore examined in the cord blood of over 300 healthy newborns enrolled in the Tucson Children's Respiratory study. Additionally these factors were measured in sera drawn from these patients between the ages of 4-9. Determinations were made using commercially available sCD23 and sCD25 ELISA assays. Results indicate these markers are measurable in cord samples, they are not influenced by gender, and soluble CD23 and CD25 levels decrease with age. Increasing levels of sCD23 and sCD25 did not correlate with increasing expression of IgE. Experimental data derived in this study indicate these factors will not serve as independent, predictive indicators of future asthma, hayfever or eczema.


Files in this item

Thumbnail
Name:
azu_td_1353678_sip1_m.pdf
Size:
2.609Mb
Format:
PDF

This item appears in the following Collection(s)

Show simple item record